{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:12:35Z","timestamp":1789909955280,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,1,12]],"date-time":"2013-01-12T00:00:00Z","timestamp":1357948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00192-012-2027-1","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T12:41:15Z","timestamp":1357908075000},"page":"1065-1072","source":"Crossref","is-referenced-by-count":66,"title":["Biomarkers in overactive bladder"],"prefix":"10.1007","volume":"24","author":[{"given":"Alka A.","family":"Bhide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufus","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vik","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Alessandro","family":"Digesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,12]]},"reference":[{"key":"2027_CR1","doi-asserted-by":"crossref","unstructured":"Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J et al (2010) An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 21(1):5\u201326. doi: 10.1007\/s00192-009-0976-9","DOI":"10.1007\/s00192-009-0976-9"},{"issue":"3","key":"2027_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrurol.2011.7","volume":"8","author":"R Cartwright","year":"2011","unstructured":"Cartwright R, Afshan I, Derpapas A, Vijaya G, Khullar V (2011) Novel biomarkers for overactive bladder. Nat Rev Urol Mar 8(3):139\u2013145","journal-title":"Nat Rev Urol Mar"},{"issue":"3 Suppl 1","key":"2027_CR3","first-page":"3","volume":"119","author":"FM Chu","year":"2006","unstructured":"Chu FM, Dmochowski R (2006) Pathophysiology of overactive bladder. Am J Med 119 [3 Suppl 1]:3\u20138","journal-title":"Am J Med"},{"issue":"Suppl 4","key":"2027_CR4","first-page":"S7","volume":"4","author":"WD Steers","year":"2002","unstructured":"Steers WD (2002) Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 4 [Suppl 4]:S7\u2013S18","journal-title":"Rev Urol"},{"issue":"9","key":"2027_CR5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1464-410x.2000.00562.x","volume":"85","author":"R Tanner","year":"2000","unstructured":"Tanner R, Chambers P, Khadra MH, Gillespie JI (2000) The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro. BJU Int 85(9):1115\u20131119","journal-title":"BJU Int"},{"issue":"1","key":"2027_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/exnr.1999.7254","volume":"161","author":"MA Vizzard","year":"2000","unstructured":"Vizzard MA (2000) Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol 161(1):273\u2013284","journal-title":"Exp Neurol"},{"issue":"7","key":"2027_CR7","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.1464-410x.2000.00619.x","volume":"85","author":"KH Moore","year":"2000","unstructured":"Moore KH, Simons A, Mukerjee C, Lynch W (2000) The relative incidence of detrusor instability and bacterial cystitis detected on the urodynamic-test day. BJU Int 85(7):786\u2013792","journal-title":"BJU Int"},{"issue":"2","key":"2027_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00192-010-1263-5","volume":"22","author":"E Hessdoerfer","year":"2011","unstructured":"Hessdoerfer E, Jundt K, Peschers U (2011) Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder? Int Urogynecol J 22(2):229\u2013232","journal-title":"Int Urogynecol J"},{"issue":"10","key":"2027_CR9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00192-011-1506-0","volume":"22","author":"CA Walsh","year":"2011","unstructured":"Walsh CA, Siddins A, Parkin K, Mukerjee C, Moore KH (2011) Prevalence of \u201clow-count\u201d bacteriuria in female urinary incontinence versus continent female controls: a cross-sectional study. Int Urogynecol J 22(10):1267\u20131272","journal-title":"Int Urogynecol J"},{"issue":"7","key":"2027_CR10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/00001756-199805110-00038","volume":"9","author":"D Oddiah","year":"1998","unstructured":"Oddiah D, Anand P, McMahon SB, Rattray M (1998) Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder. Neuroreport 9(7):1455\u20131458","journal-title":"Neuroreport"},{"issue":"2","key":"2027_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cne.10447","volume":"454","author":"LY Qiao","year":"2002","unstructured":"Qiao LY, Vizzard MA (2002) Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways. J Comp Neurol 454(2):200\u2013211","journal-title":"J Comp Neurol"},{"issue":"5","key":"2027_CR12","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0022-5347(05)00992-4","volume":"175","author":"JC Kim","year":"2006","unstructured":"Kim JC, Park EY, Seo SI, Park YH, Hwang TK (2006) Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175(5):1773\u20131776","journal-title":"J Urol"},{"issue":"12","key":"2027_CR13","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1464-410X.2009.08380.x","volume":"103","author":"HT Liu","year":"2009","unstructured":"Liu HT, Chancellor MB, Kuo HC (2009) Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int 103(12):1668\u20131672","journal-title":"BJU Int"},{"issue":"8","key":"2027_CR14","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/nau.21118","volume":"30","author":"HT Liu","year":"2011","unstructured":"Liu HT, Lin H, Kuo HC (2011) Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Neurourol Urodyn 30(8):1525\u20131529","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"2027_CR15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.eururo.2008.04.037","volume":"56","author":"HT Liu","year":"2009","unstructured":"Liu HT, Chancellor MB, Kuo HC (2009) Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 56(4):700\u2013706","journal-title":"Eur Urol"},{"key":"2027_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1757-5672.2010.00065.x","volume":"2","author":"HC Kuo","year":"2010","unstructured":"Kuo HC, Liu HT, Tyagi P, Chancellor MB (2010) Urinary nerve growth factor levels in urinary tract diseases with or without frequency urgency syndrome. LUTS 2:88\u201394","journal-title":"LUTS"},{"issue":"3","key":"2027_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pneurobio.2008.04.004","volume":"85","author":"A Merighi","year":"2008","unstructured":"Merighi A, Salio C, Ghirri A, Lossi L, Ferrini F, Betelli C et al (2008) BDNF as a pain modulator. Prog Neurobiol 85(3):297\u2013317","journal-title":"Prog Neurobiol"},{"issue":"21","key":"2027_CR18","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.1523\/JNEUROSCI.17-21-08476.1997","volume":"17","author":"GJ Michael","year":"1997","unstructured":"Michael GJ, Averill S, Nitkunan A, Rattray M, Bennett DL, Yan Q et al (1997) Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 17(21):8476\u20138490","journal-title":"J Neurosci"},{"issue":"1\u20133","key":"2027_CR19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0165-0173(02)00206-0","volume":"40","author":"S Pezet","year":"2002","unstructured":"Pezet S, Malcangio M, McMahon SB (2002) BDNF: a neuromodulator in nociceptive pathways? Brain Res Brain Res Rev 40(1\u20133):240\u2013249","journal-title":"Brain Res Brain Res Rev"},{"issue":"3","key":"2027_CR20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroscience.2010.01.015","volume":"166","author":"R Pinto","year":"2010","unstructured":"Pinto R, Frias B, Allen S, Dawbarn D, McMahon SB, Cruz F et al (2010) Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience 166(3):907\u2013916","journal-title":"Neuroscience"},{"issue":"3","key":"2027_CR21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2010.02.031","volume":"58","author":"R Pinto","year":"2010","unstructured":"Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM et al (2010) Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome\/interstitial cystitis. Eur Urol Sep 58(3):360\u2013365","journal-title":"Eur Urol Sep"},{"issue":"2","key":"2027_CR22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1569-9056(11)60867-1","volume":"10","author":"T Antunes-Lopes","year":"2012","unstructured":"Antunes-Lopes T, Pinto R, Carvalho-Barros S, Diniz P, Martins-Silva C et al (2012) Urinary levels of brain derived neurotrophic factor (BDNF) in women with overactive bladder (OAB) syndrome correlate with the severity of symptoms. Eur Urol Suppl 10(2):277\u2013278","journal-title":"Eur Urol Suppl"},{"issue":"7","key":"2027_CR23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1464-410X.1976.tb06711.x","volume":"48","author":"MI Bultitude","year":"1976","unstructured":"Bultitude MI, Hills NH, Shuttleworth KE (1976) Clinical and experimental studies on the action of prostaglandins and their synthesis inhibitors on detrusor muscle in vitro and in vivo. Br J Urol 48(7):631\u2013637","journal-title":"Br J Urol"},{"issue":"6","key":"2027_CR24","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0022-5347(01)67397-X","volume":"153","author":"O Ishizuka","year":"1995","unstructured":"Ishizuka O, Mattiasson A, Andersson KE (1995) Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins. J Urol 153(6):2034\u20132038","journal-title":"J Urol"},{"key":"2027_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00300786","volume":"18","author":"B Schussler","year":"1990","unstructured":"Schussler B (1990) Comparison of the mode of action of prostaglandin E2 (PGE2) and sulprostone, a PGE2-derivative, on the lower urinary tract in healthy women. A urodynamic study. Urol Res 18:349\u2013352","journal-title":"Urol Res"},{"issue":"11","key":"2027_CR26","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1464-410X.2009.08851.x","volume":"106","author":"HT Liu","year":"2010","unstructured":"Liu HT, Tyagi P, Chancellor MB, Kuo HC (2010) Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis\/bladder pain syndrome and detrusor overactivity. BJU Int 106(11):1681\u20131685","journal-title":"BJU Int"},{"issue":"3","key":"2027_CR27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11255-009-9647-5","volume":"42","author":"P Tyagi","year":"2010","unstructured":"Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y et al (2010) Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 42(3):629\u2013635","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"2027_CR28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00192-011-1401-8","volume":"22","author":"G Ghoniem","year":"2011","unstructured":"Ghoniem G, Faruqui N, Elmissiry M, Mahdy A, Abdelwahab H, Oommen M et al (2011) Differential profile analysis of urinary cytokines in patients with overactive bladder. Int Urogynecol J 22(8):953\u2013961","journal-title":"Int Urogynecol J"},{"key":"2027_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.1982.tb22124.x","volume":"389","author":"I Kushner","year":"1982","unstructured":"Kushner I (1982) The phenomenon of the acute phase response. Ann N Y Acad Sci 389:39\u201348","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"2027_CR30","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805\u20131812","journal-title":"J Clin Invest"},{"issue":"7","key":"2027_CR31","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00192-012-1715-1","volume":"23","author":"SM Hsiao","year":"2012","unstructured":"Hsiao SM, Lin HH, Kuo HC (2012) The role of serum C-reactive protein in women with lower urinary tract symptoms. Int Urogynecol J 23(7):935-940 doi: 10.1007\/s00192-012-1715-1","journal-title":"Int Urogynecol J"},{"issue":"3","key":"2027_CR32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1879-5226(10)60028-0","volume":"21","author":"YC Chuang","year":"2010","unstructured":"Chuang YC, Tyagi V, Liu RT, Chancellor MB, Tyagi P (2010) Urine and serum C-reactive protein levels as potential biomarkers of lower urinary tract symptoms. Urol Sci 21(3):132\u2013136","journal-title":"Urol Sci"},{"issue":"3","key":"2027_CR33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/nau.20938","volume":"30","author":"SD Chung","year":"2011","unstructured":"Chung SD, Liu HT, Lin H, Kuo HC (2011) Elevation of serum c-reactive protein in patients with OAB and IC\/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn 30(3):417\u2013420","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"2027_CR34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.urology.2008.12.012","volume":"73","author":"V Kupelian","year":"2009","unstructured":"Kupelian V, McVary KT, Barry MJ, Link CL, Rosen RC, Aiyer LP et al (2009) Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey. Urology 73(5):950\u2013957","journal-title":"Urology"},{"key":"2027_CR35","doi-asserted-by":"crossref","unstructured":"Van der Hel OL, van der Luijt RB, Bueno de Mesquita HB, van Noord PA, Slothouber B, Roest M et al (2002) Quality and quantity of DNA isolated from frozen urine in population-based research. Anal Biochem 304(2):206\u2013211","DOI":"10.1006\/abio.2002.5634"},{"issue":"6","key":"2027_CR36","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.eururo.2011.03.007","volume":"59","author":"A-L Wennberg","year":"2011","unstructured":"Wennberg A-L, Altman D, Lundholm C, Klint A, Iliadou A, Peeker R et al (2011) Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins. Eur Urol 59(6):1032\u20131038","journal-title":"Eur Urol"},{"issue":"10","key":"2027_CR37","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/j.0001-6349.2004.00635.x","volume":"83","author":"G Rohr","year":"2004","unstructured":"Rohr G, Kragstrup J, Gaist D, Christensen K (2004) Genetic and environmental influences on urinary incontinence: a Danish population-based twin study of middle-aged and elderly women. Acta Obstet Gynecol Scand 83(10):978\u2013982","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2027_CR38","doi-asserted-by":"crossref","first-page":"82.e10","DOI":"10.1016\/j.ajog.2011.02.052","volume":"205","author":"CE Ferreira","year":"2011","unstructured":"Ferreira CE, Fonseca AM, Silva ID, Gir\u00e3o MJ, Sartori MG, Castro RA (2011) The relationship between the Trp 64 Arg polymorphism of the beta 3-adrenoceptor gene and idiopathic overactive bladder. Am J Obstet Gynecol 205(1):82.e10\u20134","journal-title":"Am J Obstet Gynecol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-012-2027-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-012-2027-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-012-2027-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T19:34:09Z","timestamp":1644089649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-012-2027-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,12]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2027"],"URL":"https:\/\/doi.org\/10.1007\/s00192-012-2027-1","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,12]]}}}